Patient Education : Patients should be educated about the signs and symptoms of potential adverse effects, such as severe nausea, signs of pancreatitis (e.g., severe abdominal pain), or symptoms of serotonin syndrome (e.g., rapid heart rate, hallucinations)
CagriSema (cagrilintide + semaglutide) CagriSema is a fixed-dose combination of cagrilintide (a long-acting amylin analog) and semaglutide (the GLP-1 agonist behind Ozempic and Wegovy)
2014 Jul;141(2):1509
This review summarises the literature on this topic, including a meta-analysis of published studies on GLP-1 secretion in individuals with and without diabetes after oral glucose and mixed meals
Collagen masks reduce the appearance of early sagging and wrinkles
Hepatocyte cell lines have become high-quality in vitro models due to their advantages, such as strong repeatability, stable subculture and controllable conditions